FAB4-guided P4 immune therapy for prostate cancer

King's College LondonDr Sophie Papa£50,0002013 - 2014

The project in a nutshell

Testing whether a protein drug called FAB4 can make the body's own immune system attack prostate cancer cells.

Why we funded it

If successful, FAB4-guided immunotherapy could provide a new treatment for men affected by advanced and otherwise untreatable prostate cancer, helping to improve survival and quality of life.

For more detailed information on this project, please look at the lay summary